Profile	GDS4093 / 210718_s_at
Title	Anastrozole/Fulvestrant/Gefitinib neoadjuvant therapy of estrogen receptor positive breast cancer patients: tumor core biopsies
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM832392	breast, pre AF treatment (H15_1682)	2.59261	41
GSM832398	breast, pre AF treatment (H23_2233)	4.43138	66
GSM832394	breast, pre AF treatment (H1_1278)	2.47573	33
GSM832396	breast, pre AF treatment (H12_1628)	3.30162	58
GSM832390	breast, pre AF treatment (H7_1349)	2.47218	33
GSM832400	breast, pre AFI treatment (H3_1296)	2.49144	35
GSM832402	breast, pre AFI treatment (H11_1610)	3.43089	60
GSM832408	breast, pre AFI treatment (H18_1930)	2.46846	33
GSM832406	breast, pre AFI treatment (H2_1279)	2.47661	34
GSM832410	breast, pre AFI treatment (H17_1910)	2.42507	32
GSM832404	breast, pre AFI treatment (H9_1575)	2.41494	32
GSM832393	breast, post AF treatment (H16_1717)	3.83064	63
GSM832399	breast, post AF treatment (H24_2259)	3.16	56
GSM832395	breast, post AF treatment (H4_1328)	2.30045	20
GSM832397	breast, post AF treatment (H14_1659)	3.60756	60
GSM832391	breast, post AF treatment (H8_1389)	2.4814	32
GSM832401	breast, post AFI treatment (H6_1346)	2.52796	35
GSM832403	breast, post AFI treatment (H13_1647)	5.00668	70
GSM832409	breast, post AFI treatment (H20_1950)	2.46874	33
GSM832407	breast, post AFI treatment (H5_1332)	2.4961	33
GSM832411	breast, post AFI treatment (H19_1935)	2.46275	33
GSM832405	breast, post AFI treatment (H10_1594)	2.47467	34